Imaging software developer Median Technologies has reported a 51% revenue increase for fiscal year 2020.
For the year (end-December 31), Median's revenues jumped to 13.5 million euros ($16.1 million) compared with revenues of 9 million euros ($10.7 million) in 2019. The company attributed the increase in part to its iCRO business unit, which provides services for oncology clinical trials.
As for its first quarter (end-March 31), Median's revenue increased 86%, from 2.8 million euros ($3.3 million U.S.) in the first quarter of 2020 to 5.2 million euros ($6.2 million U.S.) for the same period this year.
